[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
August 8, 2001

Statins and Fracture Risk

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;286(6):669-670. doi:10.1001/jama.286.6.669

To the Editor: Dr van Staa and colleagues1 concluded that "use of statins . . . was not associated with a reduction in risk of fracture." This conclusion is contrary to the results of our study2 as well as others.3,4 Our results, like those of van Staa et al, were derived from the General Practice Research Database (GPRD). However, the study by van Staa et al encompassed 683 practices originally considered to have data of satisfactory quality; by contrast, the Boston Collaborative Drug Surveillance Program conducts ongoing internal (unpublished) validation studies to identify practices that provide unsatisfactory data. As a result, several practices were excluded and our recent study encompassed only 340 practices. Van Staa et al also failed to exclude patients at high risk for fracture, for instance patients with osteoporosis, osteomalacia, cancer, alcoholism, and those receiving bisphosphonates. We excluded such patients since it is well recognized that including persons who are already at high risk for an outcome will dilute the effect of a drug on the outcome.5 These methodological differences resulted in van Staa et al identifying 81 880 fracture cases, while we identified only 3940.

First Page Preview View Large
First page PDF preview
First page PDF preview
×